Entyvio’s dosage is an intravenous (IV) infusion every 8 weeks or a subcutaneous injection every 2 weeks. The starting dosage is two infusions 2 weeks apart. After that, you’ll continue with ...

The full CMI on the next page has more details. If you are worried about using this medicine, speak to your doctor or pharmacist. Entyvio contains the active ingredient vedolizumab. Entyvio is ...

More than three years after it was first rejected by the FDA, Takeda's subcutaneous (SC) formulation of Entyvio has been resubmitted as a maintenance therapy for ulcerative colitis. The new ...